Medina-Vera, D.; Zhao, H.; Bereczki, E.; Rosell-Valle, C.; Shimozawa, M.; Chen, G.; de Fonseca, F.R.; Nilsson, P.; Tambaro, S.
The Expression of the Endocannabinoid Receptors CB2 and GPR55 Is Highly Increased during the Progression of Alzheimer’s Disease in AppNL-G-F Knock-In Mice. Biology 2023, 12, 805.
https://doi.org/10.3390/biology12060805
AMA Style
Medina-Vera D, Zhao H, Bereczki E, Rosell-Valle C, Shimozawa M, Chen G, de Fonseca FR, Nilsson P, Tambaro S.
The Expression of the Endocannabinoid Receptors CB2 and GPR55 Is Highly Increased during the Progression of Alzheimer’s Disease in AppNL-G-F Knock-In Mice. Biology. 2023; 12(6):805.
https://doi.org/10.3390/biology12060805
Chicago/Turabian Style
Medina-Vera, Dina, Hongjing Zhao, Erika Bereczki, Cristina Rosell-Valle, Makoto Shimozawa, Gefei Chen, Fernando RodrÃguez de Fonseca, Per Nilsson, and Simone Tambaro.
2023. "The Expression of the Endocannabinoid Receptors CB2 and GPR55 Is Highly Increased during the Progression of Alzheimer’s Disease in AppNL-G-F Knock-In Mice" Biology 12, no. 6: 805.
https://doi.org/10.3390/biology12060805
APA Style
Medina-Vera, D., Zhao, H., Bereczki, E., Rosell-Valle, C., Shimozawa, M., Chen, G., de Fonseca, F. R., Nilsson, P., & Tambaro, S.
(2023). The Expression of the Endocannabinoid Receptors CB2 and GPR55 Is Highly Increased during the Progression of Alzheimer’s Disease in AppNL-G-F Knock-In Mice. Biology, 12(6), 805.
https://doi.org/10.3390/biology12060805
